Our Pricing

Private Weight Loss Clinic Cambridge: Expert Prescription Treatment

Published: 30 September 2026

Finding a trusted private weight loss clinic Cambridge service that combines clinical expertise with convenient online access has become essential for patients seeking prescription weight loss medications. As a UK-registered pharmacy with a dedicated clinical team, Cured Pharmacy provides Cambridge residents with access to licensed GLP-1 treatments including Mounjaro, Wegovy, and Saxenda from £124.99, all following comprehensive online assessment by GMC-registered prescribers. Every consultation is conducted to MHRA standards, ensuring safe, evidence-based weight management support tailored to your individual health profile.

What Makes a Private Weight Loss Clinic Cambridge Service Effective?

A reputable private weight loss clinic Cambridge offering must combine three core elements: access to MHRA-licensed prescription medications, clinical assessment by UK-registered prescribers, and ongoing patient support throughout treatment. Unlike over-the-counter supplements, prescription weight loss medications such as tirzepatide (Mounjaro) and semaglutide (Wegovy) require thorough medical evaluation to ensure suitability, safety, and optimal dosing strategies tailored to each patient's metabolic profile and comorbidities [1].

Clinical trials demonstrate that GLP-1 receptor agonists can support average weight reductions of 15-22% of initial body weight when combined with lifestyle modifications [2]. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure compliance with UK pharmaceutical standards. Cambridge patients benefit from transparent pricing—£124.99 for Mounjaro, £124.99 for Wegovy, and £124.99 for Saxenda—with no hidden consultation fees and discreet home delivery across Cambridgeshire within 24-48 hours of prescriber approval.

Private Weight Loss Clinic Cambridge: Available Prescription Treatments

When selecting a private weight loss clinic Cambridge service, understanding which prescription medications are available and evidence-based is crucial. Cured Pharmacy offers the full spectrum of NICE-recognised weight loss treatments, each with distinct mechanisms of action and clinical indications. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that demonstrated superior weight loss outcomes in the SURPASS-2 trial, with participants achieving up to 22.5% body weight reduction over 72 weeks [3].

Wegovy (semaglutide) operates as a GLP-1 receptor agonist and showed average weight loss of 15% in the STEP 1 trial, making it highly effective for patients with BMI ≥30 or ≥27 with weight-related conditions [4]. For those preferring oral medication, Wegovy tablets provide comparable efficacy to injectable formulations. Saxenda (liraglutide) offers once-daily injections with proven cardiovascular benefits, while Orlistat and Xenical work through lipase inhibition for patients seeking non-GLP-1 options. All treatments require clinical assessment to determine the most appropriate choice based on medical history, current medications, and weight loss goals.

GLP-1 Medications vs Lipase Inhibitors

The choice between GLP-1 receptor agonists and lipase inhibitors depends on individual patient factors. GLP-1 medications (Mounjaro, Wegovy, Saxenda) work by mimicking incretin hormones that regulate appetite and glucose metabolism, leading to reduced caloric intake and improved glycaemic control. These are typically recommended for patients with BMI ≥30 or ≥27 with comorbidities such as type 2 diabetes or hypertension. Lipase inhibitors like Orlistat and Xenical block dietary fat absorption in the gastrointestinal tract, making them suitable for patients who prefer non-injectable options or have contraindications to GLP-1 therapy. Our prescribers evaluate each patient's medical profile to recommend the most clinically appropriate treatment pathway.

How the Private Weight Loss Clinic Cambridge Consultation Works

Accessing our private weight loss clinic Cambridge service begins with a confidential online consultation that takes under three minutes to complete. Patients provide detailed health information including current weight, height, medical history, existing medications, and any previous weight loss attempts. This information is reviewed by a UK-registered prescriber who assesses suitability for prescription weight loss medication according to NICE guidelines and MHRA licensing criteria.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (9012511) where it is dispensed by our qualified pharmacy team. Medications are packaged discreetly and dispatched via tracked courier, typically arriving within 24-48 hours across Cambridge and surrounding areas. Ongoing support is provided through our clinical team, with regular check-ins to monitor progress, adjust dosing as needed, and address any questions or side effects. This comprehensive approach ensures Cambridge patients receive the same standard of care as traditional clinic-based services, with the added convenience of home delivery and flexible consultation times.

Eligibility Criteria for Prescription Weight Loss Treatment

To qualify for prescription weight loss medication through our private weight loss clinic Cambridge service, patients typically need a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Prescribers also consider contraindications including pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe renal impairment, or uncontrolled psychiatric conditions. A thorough medication review is conducted to identify potential drug interactions, particularly with insulin, sulphonylureas, or warfarin, which may require dose adjustments under medical supervision.

Private Weight Loss Clinic Cambridge Pricing and Discount Codes

Transparent pricing is a cornerstone of our private weight loss clinic Cambridge offering. Unlike many providers who hide costs until after consultation, Cured Pharmacy displays all treatment prices upfront: Mounjaro from £124.99, Wegovy from £124.99, Saxenda from £124.99, and Orlistat from £124.99. New patients receive £20 off their first order using code Weightlossnew, bringing the starting price to £124.99 for eligible treatments.

All prices include the clinical consultation, prescription, medication, and discreet home delivery—no hidden fees or subscription traps. We guarantee the lowest UK prices for genuine, MHRA-licensed medications dispensed by our GPhC-registered pharmacy. Cambridge residents benefit from same competitive pricing as all UK customers, with no regional surcharges. Payment is secure, and refunds are available if a prescriber determines treatment is not clinically appropriate following consultation.

Clinical Evidence Supporting Private Weight Loss Clinic Cambridge Treatments

The prescription medications available through our private weight loss clinic Cambridge service are supported by extensive clinical trial data. The SURPASS-2 trial comparing tirzepatide (Mounjaro) to semaglutide found that tirzepatide 15mg produced superior weight loss, with participants losing an average of 12.4kg compared to 6.2kg with semaglutide 1mg over 40 weeks [5]. The STEP programme evaluating semaglutide (Wegovy) across multiple trials demonstrated consistent weight reductions of 12-15% when combined with lifestyle intervention, with significant improvements in cardiovascular risk markers including blood pressure, lipid profiles, and HbA1c in diabetic patients [6].

Liraglutide (Saxenda) has been studied in over 5,000 patients across the SCALE trial programme, showing average weight loss of 8% and reduced progression to type 2 diabetes in prediabetic individuals [7]. These robust evidence bases inform our prescribers' clinical decision-making, ensuring Cambridge patients receive treatments with proven efficacy and safety profiles. All medications are prescribed in accordance with their UK marketing authorisations and NICE technology appraisals where applicable.

Long-Term Weight Maintenance and Sustainability

Clinical data indicate that GLP-1 receptor agonists support sustained weight loss when continued long-term, with weight regain commonly observed upon discontinuation [8]. Our private weight loss clinic Cambridge approach emphasises that prescription medication is most effective when integrated with dietary modifications, increased physical activity, and behavioural support. Prescribers work with patients to establish realistic weight loss goals—typically 5-10% of initial body weight within the first 12-16 weeks—and adjust treatment plans based on individual response. Regular monitoring allows early identification of plateaus or adverse effects, enabling timely intervention to optimise outcomes and minimise risks.

Why Choose Cured Pharmacy as Your Private Weight Loss Clinic Cambridge Provider

Selecting the right private weight loss clinic Cambridge service requires confidence in clinical governance, medication authenticity, and patient support. Cured Pharmacy operates under the direct oversight of superintendent pharmacist Tarun Kumar (GPhC 2233073), ensuring every prescription meets GPhC and MHRA standards. Our pharmacy registration (9012511) is publicly verifiable on the General Pharmaceutical Council register, providing transparency and accountability that unregulated online sellers cannot offer.

We supply only genuine, UK-licensed medications sourced through authorised wholesalers—never grey-market imports or counterfeit products. Cambridge patients benefit from rapid delivery, typically within 24-48 hours of prescriber approval, in fully discreet packaging with no external branding. Our clinical team is available via phone (+44 116 4646009) or email to address questions about dosing, side effects, or treatment adjustments. With transparent pricing, no subscription lock-ins, and a commitment to evidence-based prescribing, Cured Pharmacy delivers the clinical rigour of a traditional private weight loss clinic Cambridge service with the convenience of digital healthcare.

Scientific References

1. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 30 September 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 30 September 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 30 September 2026]
4. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 30 September 2026]
5. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 30 September 2026]
6. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA, 325(14), 1414-1425. [accessed 30 September 2026]
7. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 30 September 2026]
8. Wilding, J. P., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. [accessed 30 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 30 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 30 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 30 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.